Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 27 Apr 2021

Current Status and Trends in Peptide Receptor Radionuclide Therapy in the Past 20 Years (2000–2019): A Bibliometric Study

in Drugs Outcomes Research and Policies

Xiaojing Lu
Cuncun Lu
Yongjie Yang
Xiangfen Shi
Haibo Wang
Nan Yang
Kehu Yang
Xiaojian Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.624534

7,150 views
35 citations

Original Research

Published on 27 Apr 2021

Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate

in Drugs Outcomes Research and Policies

Hernán Ramos
Juan Pardo
Rafael Sánchez
Esteve Puchades
Jordi Pérez-Tur
Andrés Navarro
Lucrecia Moreno

Frontiers in Pharmacology

doi 10.3389/fphar.2021.579489

6,215 views
16 citations

Original Research

Published on 26 Apr 2021

Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation

in Drugs Outcomes Research and Policies

Kojiro Takamoto
Jun-ichi Sakamoto
Satoyasu Ito
Takeshi Kimura
Eri Manabe
Toshiyuki Shikata
Masanori Asakura
Masaharu Ishihara
Takeshi Tsujino

Frontiers in Pharmacology

doi 10.3389/fphar.2021.651799

2,757 views
6 citations

Original Research

Published on 26 Apr 2021

Lack of Awareness of the Impact of Improperly Disposed Of Medications and Associated Factors: A Cross-Sectional Survey in Indonesian Households

in Drugs Outcomes Research and Policies

Sofa D. Alfian
Widya N. Insani
Eli Halimah
Nabilla A. Qonita
Siti S. Jannah
Nisa M. Nuraliyah
Woro Supadmi
Vesara A. Gatera
Rizky Abdulah

Frontiers in Pharmacology

doi 10.3389/fphar.2021.630434

7,970 views
14 citations

Original Research

Published on 23 Apr 2021

Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery

in Drugs Outcomes Research and Policies

Shao-Yu Yang
Tao-Min Huang
Tai-Shuan Lai
Nai-Kuan Chou
Chun-Hao Tsao
Yi-Ping Huang
Shuei-Liong Lin
Yung-Ming Chen
Vin-Cent Wu
NSARF study group

Frontiers in Pharmacology

doi 10.3389/fphar.2021.662301

3,171 views
3 citations

Perspective

Published on 23 Apr 2021

From Precision Metapharmacology to Patient Empowerment: Delivery of Self-Care Practices for Epilepsy, Pain, Depression and Cancer Using Digital Health Technologies

in Drugs Outcomes Research and Policies

Grzegorz Bulaj
Jacqueline Clark
Maryam Ebrahimi
Elizabeth Bald

Frontiers in Pharmacology

doi 10.3389/fphar.2021.612602

17,608 views
13 citations

Original Research

Published on 22 Apr 2021

No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison

in Drugs Outcomes Research and Policies

Roberta Gagliardini
Alessandro Cozzi-Lepri
Andrea Mariano
Fabrizio Taglietti
Alessandra Vergori
Amina Abdeddaim
Francesco Di Gennaro
Valentina Mazzotta
Alessandra Amendola
Giampiero D’Offizi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.621676

3,196 views
7 citations

Methods

Published on 22 Apr 2021

Effectiveness of Trainings of General Practitioners on Antibiotic Stewardship: Methods of a Pragmatic Quasi-Experimental Study in a Controlled Before-After Design in South-East-Lower Saxony, Germany (WASA)

in Drugs Outcomes Research and Policies

Daniela Gornyk
Martina Scharlach
Brigitte Buhr-Riehm
Carolina Judith Klett-Tammen
Sveja Eberhard
Jona Theodor Stahmeyer
Anika Großhennig
Andrea Smith
Sarah Meinicke
Wilfried Bautsch

Frontiers in Pharmacology

doi 10.3389/fphar.2021.533248

3,978 views
4 citations

Original Research

Published on 22 Apr 2021

High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study

in Drugs Outcomes Research and Policies

Bing Zhao
Min Liu
Ping Liu
Yibing Peng
Jun Huang
Mengjiao Li
Yihui Wang
LiLi Xu
Silei Sun
Xing Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.638556

19,830 views
38 citations

Original Research

Published on 22 Apr 2021

Strategies to Approach Medicines Litigation: An Action Research Study in Brazil

in Drugs Outcomes Research and Policies

Fernanda Lacerda da Silva Machado
Danielle Maria de Souza Serio dos Santos
Luciane Cruz Lopes

Frontiers in Pharmacology

doi 10.3389/fphar.2021.612426

3,299 views
4 citations

Original Research

Published on 21 Apr 2021

Bilateral Motor Cortex tDCS Effects on Post-Stroke Pain and Spasticity: A Three Cases Study

in Drugs Outcomes Research and Policies

Andrés Molero-Chamizo
Ángeles Salas Sánchez
Belén Álvarez Batista
Carlos Cordero García
Rafael Andújar Barroso
G. Nathzidy Rivera-Urbina
Michael A. Nitsche
José R. Alameda Bailén

Frontiers in Pharmacology

doi 10.3389/fphar.2021.624582

5,555 views
9 citations

Systematic Review

Published on 21 Apr 2021

Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review

in Drugs Outcomes Research and Policies

Khadidja Abdallah
Isabelle Huys
Kathleen Claes
Steven Simoens

Frontiers in Pharmacology

doi 10.3389/fphar.2021.630949

6,713 views
12 citations

Mini Review

Published on 20 Apr 2021

Injection-Based Management of Osteoarthritis of the Knee: A Systematic Review of Guidelines

in Drugs Outcomes Research and Policies

Vito Pavone
Andrea Vescio
Matteo Turchetta
Serena Maria Chiara Giardina
Annalisa Culmone
Gianluca Testa

Frontiers in Pharmacology

doi 10.3389/fphar.2021.661805

23,678 views
42 citations

Original Research

Published on 20 Apr 2021

Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial

in Drugs Outcomes Research and Policies

James P. Sheppard
Mark Lown
Jenni Burt
Gary A. Ford
F. D. Richard Hobbs
Paul Little
Jonathan Mant
Rupert A. Payne
Richard J. McManus
On behalf of the OPTiMISE Investigators

Frontiers in Pharmacology

doi 10.3389/fphar.2021.619088

5,572 views
11 citations

Original Research

Published on 20 Apr 2021

Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer

in Drugs Outcomes Research and Policies

Na Li
Huanrui Zheng
Yanlei Huang
Bin Zheng
Hongfu Cai
Maobai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.632818

6,552 views
15 citations

Original Research

Published on 20 Apr 2021

Who Suffers From Pharmaceutical Poverty and What Are Their Needs? Evidence From a Spanish Region

in Drugs Outcomes Research and Policies

Maria Rubio-Valera
Silvia Marqués-Ercilla
M Teresa Peñarrubia-María
Rosa M. Urbanos-Garrido
Carme Borrell
Jordi Bosch
Alba Sánchez-Viñas
Ignacio Aznar-Lou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.617687

6,688 views
1 citation

Navigation group

Articles

Current Status and Trends in Peptide Receptor Radionuclide Therapy in the Past 20 Years (2000–2019): A Bibliometric Study

Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate

Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation

Lack of Awareness of the Impact of Improperly Disposed Of Medications and Associated Factors: A Cross-Sectional Survey in Indonesian Households

Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery

From Precision Metapharmacology to Patient Empowerment: Delivery of Self-Care Practices for Epilepsy, Pain, Depression and Cancer Using Digital Health Technologies

No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison

Effectiveness of Trainings of General Practitioners on Antibiotic Stewardship: Methods of a Pragmatic Quasi-Experimental Study in a Controlled Before-After Design in South-East-Lower Saxony, Germany (WASA)

High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study

Strategies to Approach Medicines Litigation: An Action Research Study in Brazil

Bilateral Motor Cortex tDCS Effects on Post-Stroke Pain and Spasticity: A Three Cases Study

Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review

Injection-Based Management of Osteoarthritis of the Knee: A Systematic Review of Guidelines

Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial

Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Who Suffers From Pharmaceutical Poverty and What Are Their Needs? Evidence From a Spanish Region